5:50 PM
 | 
Nov 01, 2007
 |  BC Extra  |  Company News

FDA accepts Indevus' Nebido NDA

FDA accepted for review IDEV's NDA for Nebido testosterone depot to treat male hypogonadism. The PDUFA...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >